Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/50747
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2020-01-22T09:25:07Z-
dc.date.available2020-01-22T09:25:07Z-
dc.date.issued2018-10-
dc.identifier.citationCamilleri, M., Borg, J. J., Sammut Bartolo, N., & Serracino-Inglott, A. (2018, October). A comparison of approved indications between regulatory agencies. Poster session presented at the ACCP Global Conference on Clinical Pharmacy, Seattle, Washington, USA.en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar/handle/123456789/50747-
dc.description.abstractA poster presentation regarding a comparison of approved indications between regulatory agencies. Introduction: Medicinal products are allowed on the market following approval by autonomous regulatory agencies which are tasked with their evaluation. Differences in evaluation practices during the registration of medicinal products are found in Europe and the United States of America which may lead to discrepancies in clinical guidelines, pricing policies, and drug use. Aims: To compare the differences in the indications of medicinal products authorised by the European Medicines Agency (EMA) and the US Food & Drug Administration using new molecular entity cardiology-related medicinal products as examples.en_GB
dc.language.isoenen_GB
dc.publisherUniversity of Malta. Department of Pharmacyen_GB
dc.rightsinfo:eu-repo/semantics/openAccessen_GB
dc.subjectDrug evaluation -- Standardsen_GB
dc.subjectAdministrative agencies -- Medical careen_GB
dc.subjectEuropean Agency for the Evaluation of Medicinal Productsen_GB
dc.subjectDrugs -- Law and legislation -- United Statesen_GB
dc.subjectDrugs -- Law and legislation -- Europeen_GB
dc.subjectCardiovascular agentsen_GB
dc.titleA comparison of approved indications between regulatory agenciesen_GB
dc.typepresentationen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.description.reviewedN/Aen_GB
dc.contributor.creatorCamilleri, Matthew-
dc.contributor.creatorBorg, John-Joseph-
dc.contributor.creatorSammut Bartolo, Nicolette-
dc.contributor.creatorSerracino-Inglott, Anthony-
Appears in Collections:Scholarly Works - FacM&SPha

Files in This Item:
File Description SizeFormat 
A_comparison_of_approved_indications_between_regulatory_agencies_2018.pdf335.63 kBAdobe PDFView/Open


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.